| Market Cap | €15.3M | |
| Enterprise Value | — | |
| Revenue | €359.2M | +9.1% |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | €19.3M | — |
| Diluted EPS | €0.20 | — |
| Free Cash Flow | — | — |
| DPS (FY2024) | — |
| Trailing yield | — |
| Payout ratio | 0.0% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| FY20222022-12-31 | — | — | reported |
| FY20212021-12-31 | — | — | reported |
| FY2020 |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | Trend · 5y | vs own |
|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||
| Net Margin | −7.65% | 3.64% | −2.49% | −9.76% | 5.38% | 90% | |
| OCF Margin | 3.67% | 14.61% | −0.42% | 1.95% | 5.24% | 70% | |
| ▸Returns on Capital · 2 ratios | |||||||
| ▸DuPont factors (ROE drivers) · 3 ratios | |||||||
| ▸Earnings quality · 3 ratios | |||||||
| ▸Liquidity & coverage · 3 ratios | |||||||
| ▸Working capital · 3 ratios | |||||||
| ▸Capital allocation · 3 ratios | |||||||
| Line | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | €279.6M | €333.1M | €363.6M | €329.4M | €359.2M |
| YoY % | +19.1% | +9.1% | -9.4% | +9.1% | |
| Pretax Income | -€27.6M | €6.3M | -€3.8M | -€37.9M | €37.0M |
| Income Tax | -€4.2M | -€5.8M | €5.3M | -€5.9M | €17.5M |
| Net Income (incl. NCI) | -€23.4M | €12.1M | -€9.1M | -€32.0M | €19.5M |
| Minority Interest (P&L) | €2.0M | €0 | €12,052 | -€153,713 | -€134,825 |
| YoY % | -100.0% | ||||
| Net Income | -€21.4M | €12.1M | -€9.0M | -€32.1M | €19.3M |
| EPS (Basic) | -€0.21 | €0.12 | -€0.09 | -€0.33 | €0.20 |
| EPS (Diluted) | -€0.21 | €0.12 | -€0.09 | -€0.33 | €0.20 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| — |
| — |
| reported |